Trial Profile
Kuvan (Sapropterin Dihydrochloride) for Improving Gastric Accommodation in Women With Diabetic Gastroparesis (KIGA-DG).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2019
Price :
$35
*
At a glance
- Drugs Sapropterin (Primary)
- Indications Diabetic gastroparesis
- Focus Therapeutic Use
- Acronyms KIGA-DG
- 09 Feb 2017 Status changed from recruiting to completed.
- 09 Jun 2010 New trial record